Patents by Inventor Kyoung-Je CHO

Kyoung-Je CHO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Use of statin-based drug for treatment of EML4-ALK-positive non-small cell lung cancer progressing on ALK inhibitor
    Patent number: 10688085
    Abstract: Provided are a pharmaceutical composition exhibiting therapeutic efficacy against EML4-ALK-positive non-small cell lung cancer that has acquired resistance to an ALK inhibitor and a method for treating the non-small cell lung cancer. Further, provided is information for drug selection for determining whether to administer a statin-based drug to a patient group with EML4-ALK-positive non-small cell lung cancer.
    Type: Grant
    Filed: January 13, 2017
    Date of Patent: June 23, 2020
    Assignees: UNIVERSITY-INDUSTRY FOUNDATION, YONSEI UNIVERSITY, JEUK CO., LTD.
    Inventors: Kyoung-Je Cho, Byoung Chul Cho, Mi-Ran Yun, Kyoung-Ho Pyo, Han Na Kang, Hun-Mi Choi
  • USE OF STATIN-BASED DRUG FOR TREATMENT OF EML4-ALK-POSITIVE NON-SMALL CELL LUNG CANCER RESISTANT TO ALK INHIBITOR
    Publication number: 20190046514
    Abstract: Provided are a pharmaceutical composition exhibiting therapeutic efficacy against EML4-ALK-positive non-small cell lung cancer that has acquired resistance to an ALK inhibitor and a method for treating the non-small cell lung cancer. Further, provided is information for drug selection for determining whether to administer a statin-based drug to a patient group with EML4-ALK-positive non-small cell lung cancer.
    Type: Application
    Filed: January 13, 2017
    Publication date: February 14, 2019
    Inventors: Kyoung-Je CHO, Byoung Chul CHO, Mi-Ran YOON, Kyoung-Ho PYO, Han Na KANG, Hun-Mi CHOI